Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

Key Numbers Every Entrepreneur Should Watch

Published

on

Rents across the UK have fallen slightly for the first time in more than five years—although tenants in London are still seeing new highs, according to fresh data from Rightmove.

Most of the time, it’s a host’s gut instinct that gets them their first booking. After this, the market becomes so crowded and competitive that it’s no longer sustainable to rely on intuition alone. Doing so would be costly.

Here is what the UK short-term rental market actually looks like right now, so that those who want to build a business in it will know what they need to do and where they need to be to succeed.

272,000 Listings and Counting: What Supply Growth Means for Your Occupancy

In January 2021, active listings in England numbered about 165,000, rising to over 272,000 by January 2024. This trajectory hasn’t reversed ever since. By May 2025, supply had climbed a further 7% each year, while nights reserved fell by 5%, which pushed average UK occupancy down to 43%.

More listings competing for a slightly shrinking pool of bookings means flat-rate pricing no longer holds up; under those conditions, a host charging last season’s rates is typically the one filling unsold nights at a discount rather than adjusting before the gap appears. 

The market’s headline numbers remain attractive: UK vacation rental revenue was projected to hit US$5.15 billion in 2025, growing at a 5.37% CAGR through to 2030. But revenue projections measure the market, not your property. Occupancy is where the difference shows up. Statista

Advertisement

October at 21%: The Seasonal Swing That Kills Revenue Projections

Occupancy in England peaked at 60% in July 2024 and fell to 21% by October. For a host carrying a fixed monthly cost on a property, that 39-point swing is not a market trend worth noting. It’s four months of the year when the model has to work differently or not at all. New hosts projecting annual revenue based on August figures tend to discover this in Q4, not earlier. 

Regional variation compounds this further: Wales led UK demand growth in early 2025, with a 13% increase in nights reserved, while Scotland remained flat and London saw a slight decline in occupancy. A host in Bristol was tracking the wrong number entirely; Bristol climbed to the fourth most-booked UK city in 2025, while Birmingham dropped three places, neither of which moved the national average enough to register. 

ADR Has Climbed Sharply, But RevPAR Shows Whether It’s Working

England’s average daily rate grew from £103 in January 2021 to £160 by January 2024. By August 2025, ADR had reached £330, a 15% year-on-year increase. That’s a strong headline, but ADR only measures what you charge when a booking is made, not how often the property is booked. RevPAR, which multiplies occupancy by ADR, is what reflects actual revenue performance. 

England’s RevPAR climbed from £32 in January 2021 to a peak of £113 in July 2023 before softening as new supply absorbed demand. A rising ADR against falling occupancy isn’t a win; it’s a pricing signal the market is giving you. Tracking vacation rental statistics at the property level, rather than relying on market summaries, makes that signal visible before it shows up in the monthly total. Smoobu’s statistics dashboard is built for exactly that granularity, giving hosts real-time occupancy, ADR, and RevPAR data rather than a quarterly post-mortem. 

Advertisement

Guests Are Booking Later. Pricing Set Three Weeks Out Is Already Behind.

Direct booking share fell to 45% in Q3 2025 as major OTA platforms gained ground, while guests are booking later, staying for shorter periods, and increasingly routing through third-party channels. A shorter booking window means less time to adjust rates before a night goes unsold. UK RevPAR was up 8% year on year in October 2025, and 5% in November, supported by ADR growth of between 4% and 7%, but those gains were concentrated in markets where operators adjusted pricing in response to forward-looking demand signals, not fixed rates set at the start of the season.

The hosts watching pacing data weekly are the ones capturing that upside. The ones who aren’t are finding out in December.

FAQs

What occupancy rate should a UK short-term rental host aim for? Based on 2024 to 2025 Lighthouse data, UK-wide average occupancy ranges from around 43% in slower months to 60% at peak summer. Anything consistently above 55% in off-peak periods generally indicates strong pricing and demand positioning for that market.

Does ADR or RevPAR better reflect a property’s performance? RevPAR is the more useful metric because it accounts for both rate and occupancy. A high ADR with low occupancy still means empty nights; RevPAR shows whether those two variables are working together.

Advertisement

Which UK regions have the strongest short-term rental demand right now? As of 2025, Wales leads for demand growth with a 13% increase in nights reserved. The East Midlands and North East show the strongest supply growth. London and Scotland have seen flat or declining occupancy relative to prior years.

Why are booking windows getting shorter, and does it matter? Guests are increasingly booking closer to their travel dates and routing through OTA platforms rather than direct channels. For hosts, this reduces the time available to adjust pricing before a night is lost, making real-time rate monitoring more necessary than it was two or three years ago.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Thailand’s Virtual Bank Shortlist Reaches Pivotal Phase

Published

on

Thailand's Virtual Bank Shortlist Reaches Pivotal Phase

Thailand’s initiative to introduce virtual banks has entered a critical stage, with the Bank of Thailand (BOT) enforcing strict regulatory compliance for the three remaining applicants.

Candidates, which include major consortia involving entities like CP Group, Krung Thai Bank, and SCBX, are required to finalize their organizational and business structures to meet central bank standards.

Failure to adhere to these criteria or provide sufficient justification for deviations could result in the revocation of a licence, potentially leading to a market with fewer than three operators as there are no provisions to replace disqualified applicants.

Key Points

  • Finalists: The three applicants currently under review are ACM Holding (CP Group), a consortium led by Krung Thai Bank (with AIS and OR), and SCBX (partnering with KakaoBank and WeBank).
  • Compliance Requirements: Applicants must ensure that financial businesses are separated from non-financial entities to mitigate risks and prevent conflicts of interest, such as unauthorized lending or preferential pricing for affiliates.
  • Adjustments: To meet criteria, companies may need to reduce shareholdings in conflicting businesses, surrender non-core financial licences, or restructure their holdings.
  • Approval Process: The Bank of Thailand will evaluate the applicants’ explanations on a case-by-case basis and provide recommendations to the Finance Ministry, which holds the final authority for granting licences.
  • Strict Oversight: The BOT has emphasized that there is no policy to replace failed applicants with reserves from the initial round, meaning the final number of virtual banks could be fewer than three.
  • Preparation Phase: Once in-principle approval is granted, successful applicants will be given approximately one year to ensure their systems meet security and financial stability requirements before launching.

The BOT maintains a rigorous stance, indicating that if an applicant fails to meet requirements and cannot provide a valid justification, their license will be at risk. There is no plan to replace disqualified candidates, meaning the market could potentially launch with fewer than three operators.

Advertisement
Continue Reading

Business

Rocket Lab’s Rally Changes Everything For Investors (NASDAQ:RKLB)

Published

on

Rocket Lab's Rally Changes Everything For Investors (NASDAQ:RKLB)

This article was written by

My investing journey began at 15, sparked by a deep curiosity for markets and shaped by my father’s career in finance. What started as a fascination with Warren Buffett’s annual letters quickly evolved into a full-time passion for value investing, mental models, and understanding how great businesses create long-term value. I’ve spent years independently studying financial statements, building DCF models, and analyzing companies through both fundamental and behavioral lenses. While I’m still early in my professional path, I’ve been immersed in the world of investing for nearly a decade. From dissecting shareholder letters to reverse-engineering business strategies, I’ve developed a disciplined, fundamentals-first approach grounded in long-term thinking. I focus on identifying mispriced quality companies and understanding what makes certain business models resilient across cycles. I write on Seeking Alpha to share insights, test ideas in public, and contribute to a community of investors who value clear thinking over hype. My goal is to provide thoughtful, research-backed commentary, whether on under-the-radar compounders, Growth/GARP stocks, or misunderstood tech platforms. Above all, I invest with conviction, patience, and a relentless drive to keep learning.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of RKLB either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Madison Diversified Income Fund Q1 2026 Investment Strategy Letter (MBLAX)

Published

on

Invesco SteelPath MLP Alpha Fund Q4 2025 Commentary (MLPAX)

Madison Investments is 100% employee-owned and has been based in Wisconsin’s capital city since its founding in 1974. In that time, Madison has grown from a local firm into a manager entrusted with approximately $22 billion in assets across a suite of mutual funds, active ETFs, managed accounts and customized portfolios. Note: This account is not managed or monitored by Madison Investments, and any messages sent via Seeking Alpha will not receive a response. For inquiries or communication, please use Madison Investments’ official channels.

Continue Reading

Business

Hain Celestial remains a work in progress

Published

on

Hain Celestial remains a work in progress

Current innovation is focused on functional attributes and nutrient density. 

Continue Reading

Business

Rigel Pharmaceuticals, Inc. (RIGL) M&A Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q1: 2026-05-05 Earnings Summary

EPS of $0.44 misses by $0.43

 | Revenue of $58.82M (10.28% Y/Y) misses by $3.58M

Rigel Pharmaceuticals, Inc. (RIGL) M&A Call May 12, 2026 8:00 AM EDT

Company Participants

Raymond Furey – Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary
Raul Rodriguez – President, CEO & Director
Lisa Rojkjaer – Executive VP & Chief Medical Officer
Erika Hamilton
David Santos – Executive VP & Chief Commercial Officer

Advertisement

Conference Call Participants

Joseph Pantginis – H.C. Wainwright & Co, LLC, Research Division
Kristen Kluska – Cantor Fitzgerald & Co., Research Division
Yigal Nochomovitz – Citigroup Inc., Research Division
Farzin Haque – Jefferies LLC, Research Division
Ashleigh Acker – Piper Sandler & Co., Research Division

Advertisement

Presentation

Operator

Greetings. Welcome to Rigel Pharmaceutical VEPPANU Licensing Agreement Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce our first speaker, Ray Furey, Rigel’s Executive Vice President, General Counsel and Corporate Secretary. Thank you, Mr. Furey. You may begin.

Advertisement

Raymond Furey
Executive VP, Chief Compliance Officer, General Counsel & Corporate Secretary

Welcome to our conference call to discuss Rigel’s in-licensing of VEPPANU or Vepdegestrant. The press release announcing the transaction was issued earlier this morning and can be viewed along with the slides for this presentation in the News and Events section of Investor Relations site on rigel.com.

As a reminder, during today’s call, we may make forward-looking statements regarding our plans and timing for the regulatory review of the transaction and development and commercialization of VEPPANU. In addition, as noted in the press release issued this morning and here in the presentation, this transaction is subject to customary closing conditions, including review under the Hart-Scott-Rodino Antitrust Improvements Act. The statements made today are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks are identified in the slides and in our most recent annual report on Form 10-K for the year ended December

Advertisement
Continue Reading

Business

Monex Group, Inc. 2026 Q4 – Results – Earnings Call Presentation (OTCMKTS:MNXBF) 2026-05-12

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Continue Reading

Business

Tennessee Democrats stripped of House committee seats over redistricting protests

Published

on

Tennessee Democrats stripped of House committee seats over redistricting protests


Tennessee Democrats stripped of House committee seats over redistricting protests

Continue Reading

Business

Cal-Maine acquires frozen food business

Published

on

Cal-Maine acquires frozen food business

Van’s Foods is a manufacturer of frozen breakfast foods. 

Continue Reading

Business

Air India crisis deepens ahead of final Ahmedabad crash report

Published

on

Air India crisis deepens ahead of final Ahmedabad crash report

Air India faces a leadership vacuum and mounting financial losses as it struggles to recover from the crash.

Continue Reading

Business

Vir Biotechnology, Inc. (VIR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q1: 2026-05-06 Earnings Summary

EPS of -$0.85 misses by $1.33

 | Revenue of -$29.00K (-100.96% Y/Y) misses by $109.31M

Vir Biotechnology, Inc. (VIR) Bank of America Global Healthcare Conference 2026 May 12, 2026 7:20 PM EDT

Company Participants

Marianne De Backer – President, CEO & Director

Advertisement

Conference Call Participants

Alec Stranahan – BofA Securities, Research Division

Advertisement

Presentation

Alec Stranahan
BofA Securities, Research Division

Thanks for joining the session with Vir Biotechnology. My name is Alec Stranahan. I cover SMID-cap biotech at Bank of America, and I’m the covering analyst for Vir. And it’s my pleasure to introduce Marianne De Backer, Chief Executive Officer of Vir. Marianne, thanks for being here.

Advertisement

Marianne De Backer
President, CEO & Director

Yes, my pleasure. Thank you.

Advertisement

Question-and-Answer Session

Alec Stranahan
BofA Securities, Research Division

Looking forward to the discussion. I guess just jumping right into it, you’ve effectively built a 2-engine value story for Vir. You’ve got the near-term potential from HDV, which we can talk about and the longer-term oncology platform using the PRO-XTEN technology. I guess when you look at how the market is valuing the company today, where do you see the biggest opportunity for re-rating? Is it on HDV approval and launch? Is it on the VIR-5500 progress to registrational studies? Or is it maybe the broader platform as the TCE data matures?

Advertisement

Marianne De Backer
President, CEO & Director

Sure. Yes. Thank you. And thank you, Alec, for hosting us and Bank of America for hosting Vir Biotechnology. So we are very fortunate that at Vir Biotechnology, we have multiple pathways to value creation, as you point out. Obviously, our most advanced program is our delta program, already in registrational trial, initial data are going to read out starting fourth quarter of this year. So obviously, that’s an important route to value creation near term.

And then as you mentioned, we have a portfolio of 3 clinical assets, 3 clinical

Advertisement
Continue Reading

Trending

Copyright © 2025